Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.150
+0.050 (4.55%)
At close: May 13, 2025, 4:00 PM
1.150
0.00 (0.00%)
Pre-market: May 14, 2025, 7:01 AM EDT
PACB Market Cap
PACB has a market cap or net worth of $345.10 million as of May 14, 2025. Its market cap has decreased by -6.68% in one year.
Market Cap
345.10M
Enterprise Value
704.10M
1-Year Change
-6.68%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since October 27, 2010, PACB's market cap has decreased from $823.90M to $345.10M, a decrease of -58.11%. That is a compound annual growth rate of -5.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 327.60M | -34.64% |
| Dec 31, 2024 | 501.20M | -80.90% |
| Dec 29, 2023 | 2.62B | 41.85% |
| Dec 30, 2022 | 1.85B | -59.02% |
| Dec 31, 2021 | 4.51B | -3.45% |
| Dec 31, 2020 | 4.67B | 494.29% |
| Dec 31, 2019 | 786.60M | -28.61% |
| Dec 31, 2018 | 1.10B | 259.04% |
| Dec 29, 2017 | 306.90M | -12.84% |
| Dec 30, 2016 | 352.10M | -65.19% |
| Dec 31, 2015 | 1.01B | 80.82% |
| Dec 31, 2014 | 559.40M | 61.68% |
| Dec 31, 2013 | 346.00M | 262.30% |
| Dec 31, 2012 | 95.50M | -37.79% |
| Dec 30, 2011 | 153.50M | -81.73% |
| Dec 31, 2010 | 840.40M | 2.00% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |